Candida parapsilosis Mdr1B and Cdr1B are drivers of Mrr1-mediated clinical fluconazole resistance

Previous work has demonstrated that non-synonymous mutations in the gene encoding the putative transcription factor CpMrr1 can influence fluconazole susceptibility however, the direct contribution of these mutations and how they influence fluconazole resistance in clinical isolates is poorly understood. We identified ten non-synonymous CpMRR1 mutations in a collection of 35 fluconazole resistant clinical isolates. The mutations leading to the A854V, R479K, and I283R substitutions were further examined and found to be activating mutations leading to increased fluconazole resistance. In addition to CpMDR1, we identified another major facilitator superfamily (MFS) transporter gene (CpMDR1B, CPAR2_603010) and an ATP-binding Cassette (ABC) transporter gene (CpCDR1B, CPAR2_304370), as being up-regulated in isolates carrying CpMRR1 activating mutations. Overall design: Comparing the gene expression of Candida parapsilosis azole-susceptible and -resistant isolates to corresponding strains containing SNPs in MRR1 or MRR1 gene corrected to wild-type sequence

Identifier
Source https://data.blue-cloud.org/search-details?step=~012A3342688BE98A01B0A6285DEABD60DC1CE119690
Metadata Access https://data.blue-cloud.org/api/collections/A3342688BE98A01B0A6285DEABD60DC1CE119690
Provenance
Instrument NextSeq 550; ILLUMINA
Publisher Blue-Cloud Data Discovery & Access service; ELIXIR-ENA
Contributor Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital
Publication Year 2024
OpenAccess true
Contact blue-cloud-support(at)maris.nl
Representation
Discipline Marine Science
Temporal Point 2022-04-20T00:00:00Z